David Pyrce Appointed as New CEO of Cognigenics, Inc.
STUART, Fla.–(BUSINESS WIRE)–#Anxiety–Cognigenics, Inc., a leader in innovative RNA-based gene therapies targeting memory loss, cognitive decline,... Read more.
EV Connect to Help Streamline Charging Experience for GM’s EV Drivers
GM and EV Connect enable Plug and Charge capabilities to help support seamless and hassle-free charging experience for EV drivers EL SEGUNDO, Calif.–(BUSINESS... Read more.
WiSA E Expands Market Reach to 40+ million TVs with Latest HDTV Licensee
WiSA Technologies Secures 5-Year WiSA E Licensing Deal with a Second Top 5 HDTV Brand BEAVERTON, Ore.–(BUSINESS WIRE)–WiSA Association, a subsidiary... Read more.
Flip Electronics Partners with Ampleon to Extend the Life of Ampleon’s Legacy LDMOS Portfolio
ALPHARETTA, Ga.–(BUSINESS WIRE)–#O2Investment–O2 Investment Partners (www.o2investment.com) is pleased to announce that Flip Electronics (www.flipelectronics.com),... Read more.
Advanced Energy Announces Fourth Quarter 2023 Earnings Date on February 6
DENVER–(BUSINESS WIRE)–Advanced Energy (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions,... Read more.
New CensisAI2 Instrument Recovery Aims to Significantly Reduce Instrumentation Costs
Provides crucial insights to streamline surgical instrument management FRANKLIN, Tenn.–(BUSINESS WIRE)–Each year, missing surgical instruments cost organizations... Read more.
FB Financial Corporation Reports Fourth Quarter 2023 Financial Results
Reports Q4 Diluted EPS of $0.63, Adjusted Diluted EPS* of $0.77 NASHVILLE, Tenn.–(BUSINESS WIRE)–FB Financial Corporation (the “Company”) (NYSE:... Read more.
Cascadia Expands Investment Banking Platform with Acquisition of Threadstone Capital
Acquisition bolsters consumer & retail coverage capabilities and expands east coast presence NEW YORK–(BUSINESS WIRE)–Cascadia Capital, LLC, one... Read more.
HealthTrust Performance Group® Showcases Pharmacy Expertise at HSCA National Pharmacy Forum
NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthTrust Performance Group®, a leading healthcare performance improvement organization supporting providers across... Read more.
Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Diego
Presentation by Director of Discovery Dr. Erik Procko shows two preclinical candidates designed have extended half-life, reduced reactivity with pre-existing anti-IdeS... Read more.